You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 14, Issue 4

February-2 2022 - 245 articles

Cover Story: Cancer is a disease with one of the highest mortality rates worldwide. Of the current strategies to study new diagnostic and treating tools, organs-on-a-chip are quite promising regarding the achievement of more personalized medicine. In this review, 75 out of 820 of the most recent published scientific articles were selected and analyzed through a systematic process, following the research guidelines for systematic reviews proposed by PRISMA. The selected articles present different advanced microfluidic platforms where cell culture models were used for the evaluation of cancer treatments’ efficacy and/or toxicity. Overall, the use of organs-on-a-chip presents several advantages when compared to 2D cultures. The combination of different organ models on a chip also contributes to a more accurate evaluation of drug effects. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (245)

  • Review
  • Open Access
16 Citations
4,167 Views
21 Pages

21 February 2022

High-grade serous ovarian cancer (HGSOC) is the most frequent and aggressive form of ovarian cancer, representing an important challenge for clinicians. Half of HGSOC cases have homologous recombination deficiency (HRD), which has specific causes (ma...

  • Article
  • Open Access
9 Citations
4,935 Views
16 Pages

Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry

  • Xavier Cheng-Hong Tsai,
  • Tzu-Ting Chen,
  • Jyh-Pyng Gau,
  • Po-Nan Wang,
  • Yi-Chang Liu,
  • Ming-Yu Lien,
  • Chi-Cheng Li,
  • Ming Yao and
  • Bor-Sheng Ko

21 February 2022

Background: The two most noteworthy strategies for haploidentical stem cell transplantation (haplo-HSCT) are posttransplantation cyclophosphamide (PTCy) with or without thymoglobulin (ATG) and granulocyte colony stimulating factor-primed bone marrow...

  • Review
  • Open Access
9 Citations
4,278 Views
16 Pages

21 February 2022

Survival of patients with breast cancer has increased in recent years due to the improvement of systemic treatment options. Nevertheless, the occurrence of brain metastases is associated with a poor prognosis. Moreover, most drugs do not penetrate th...

  • Article
  • Open Access
4 Citations
2,980 Views
13 Pages

21 February 2022

Receptor tyrosine kinases (RTKs) are important targets for clear cell renal cell carcinoma (ccRCC) treatment. Myoferlin is a strong regulator of RTKs. To identify myoferlin-associated RTKs and their prognostic implications in ccRCC, we investigated t...

  • Review
  • Open Access
58 Citations
8,326 Views
31 Pages

Glioblastoma Microenvironment and Cellular Interactions

  • Carmen-Bianca Crivii,
  • Adina Bianca Boșca,
  • Carmen Stanca Melincovici,
  • Anne-Marie Constantin,
  • Mariana Mărginean,
  • Eleonora Dronca,
  • Rada Suflețel,
  • Diana Gonciar,
  • Maria Bungărdean and
  • Alina Șovrea

21 February 2022

The central nervous system (CNS) represents a complex network of different cells, such as neurons, glial cells, and blood vessels. In tumor pathology, glial cells result in the highest number of cancers, and glioblastoma (GB) is considered the most l...

  • Article
  • Open Access
6 Citations
4,316 Views
23 Pages

Organotypic Epithelial Raft Cultures as a Three-Dimensional In Vitro Model of Merkel Cell Carcinoma

  • Arturo Temblador,
  • Dimitrios Topalis,
  • Joost van den Oord,
  • Graciela Andrei and
  • Robert Snoeck

21 February 2022

Merkel cell carcinoma (MCC) is a rare type of skin cancer for which an in vitro model is still lacking. MCC tumorigenesis is associated either with the integration of Merkel cell polyomavirus into the host genome, or with the accumulation of somatic...

  • Review
  • Open Access
42 Citations
5,818 Views
24 Pages

The Roles of microRNAs in Cancer Multidrug Resistance

  • Lucia Pavlíková,
  • Mário Šereš,
  • Albert Breier and
  • Zdena Sulová

21 February 2022

Cancer chemotherapy may induce a multidrug resistance (MDR) phenotype. The development of MDR is based on various molecular causes, of which the following are very common: induction of ABC transporter expression; induction/activation of drug-metaboli...

  • Article
  • Open Access
17 Citations
3,775 Views
19 Pages

Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study

  • Emiel A. De Jaeghere,
  • Heini Kanervo,
  • Roos Colman,
  • Wim Schrauwen,
  • Paulien West,
  • Nele Vandemaele,
  • Aglaja De Pauw,
  • Celine Jacobs,
  • Ingeborg Hilderson and
  • Michael Saerens
  • + 8 authors

21 February 2022

Purpose: This longitudinal survey study aimed to investigate the self-reported outcome measures of COVID-19 peritraumatic distress, depression, anxiety, stress, quality of life (QOL), and their associated factors in a cohort of cancer patients treate...

  • Article
  • Open Access
9 Citations
4,263 Views
26 Pages

Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

  • María del Pilar Chantada-Vázquez,
  • Mercedes Conde-Amboage,
  • Lucía Graña-López,
  • Sergio Vázquez-Estévez,
  • Susana B. Bravo and
  • Cristina Núñez

21 February 2022

Despite the increasing use of neoadjuvant chemotherapy (NAC) in HER2-positive breast cancer (BC) patients, the clinical problem of predicting individual treatment response remains unanswered. Furthermore, the use of ineffective chemotherapeutic regim...

of 25

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694